排序方式： 共有27条查询结果，搜索用时 218 毫秒
1.
2.
Taesik Yun Yoonhoi Koo Sanggu Kim Wonguk Lee Hakhyun Kim Dongwoo Chang Soochong Kim Mhan-Pyo Yang Byeong-Teck Kang 《The Veterinary quarterly》2021,41(1):163
An 8-year-old neutered male Yorkshire Terrier dog presented with head pressing, vestibular ataxia, neck tenderness, and no oculocephalic reflex. A demarcated lesion in the pons was identified on MRI. The patient was tentatively diagnosed with a glioma and was treated with hydroxyurea plus imatinib and prednisolone. After 30 days of therapeutic treatment, the patient showed a clear improvement in neurological signs, which lasted for 1117 days. On day 569 after the initiation of treatment, 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) was performed with no significant findings on visual analysis. The average and maximal standardized uptake values (SUVs) were 1.92 and 2.29, respectively. The tumor-to-normal-tissue (T/N) ratio was 0.97. The first evidence of clinical deterioration was noticed on day 1147. On day 1155, 3,4-dihydroxy-6-[18F]-fluoro-l-phenylalanine (18F-FDOPA)-PET was performed. High uptake of 18F-FDOPA was observed in the intracranial lesion. The mean and maximal SUVs of the tumor were 1.59 and 2.29, respectively. The T/N ratio was 2.22. The patient was euthanized on day 1155 and histopathologic evaluations confirmed glioma (astrocytoma). This case shows that chemotherapy with hydroxyurea plus imatinib may be considered in the treatment of canine glioma. Furthermore, this is the first case describing the application of 18F-FDG and 18F-FDOPA in a dog with glioma. 相似文献
3.
A comparison of clinical,magnetic resonance imaging and pathological findings in dogs with gliomatosis cerebri,focusing on cases with minimal magnetic resonance imaging changes‡ 
下载免费PDF全文
下载免费PDF全文 R. T. Bentley G. N. Burcham H. G. Heng J. M. Levine R. Longshore S. Carrera‐Justiz K. Kopf M. A. Miller 《Veterinary and comparative oncology》2016,14(3):318-330
The primary study objective was to determine whether clinical examination and magnetic resonance imaging (MRI) can underestimate canine gliomatosis cerebri (GC); we also investigated immunohistochemical features. Seven dogs with GC were studied; four recruited specifically because of minimal MRI changes. Neuroanatomic localization and the distribution of MRI, gross and sub‐gross lesions were compared with the actual histological distribution of neoplastic cells. In six cases, clinical examination predicted focal disease and MRI demonstrated a single lesion or appeared normal. Neoplastic cells infiltrated many regions deemed normal by clinical examination and MRI, and were Olig2‐positive and glial fibrillary acid protein‐negative. Four dogs had concurrent gliomas. GC is a differential diagnosis for dogs with focal neurological deficits and a normal MRI or a focal MRI lesion. Canine GC is probably mainly oligodendrocytic. Type II GC, a solid glioma accompanying diffuse central nervous system neoplastic infiltration, occurs in dogs as in people. 相似文献
4.
目的探讨羟基磷灰石纳米粒子运载Star3 shRNA对鼠胶质瘤C6细胞的促凋亡作用,并探讨相关机制．方法羟基磷灰石纳米粒子包被的Stat3 shRNA转染到c6胶质瘤细胞内,MTT法检测细胞增殖情况,应用流式细胞术及吖啶橙染色观察细胞周期分布及凋亡情况,TUNEL染色观察细胞的凋亡及增殖情况．结果羟基磷灰石纳米粒子运载Star3 shRNA转染C6细胞后,呈时间依赖性抑制C6细胞生长和增殖．通过流式细胞术检测证实：该质粒可使细胞阻滞在细胞周期的GO／G1期,细胞凋亡率明显增加（P＜0．05）,与对照组比较差异有统计学意义;吖啶橙及TUNEL染色发现其明显促进细胞凋亡（P＜0．05）,与对照组比较差异有统计学意义;结论羟基磷灰石纳米粒子运载Stat3 shRNA体外可明显抑制胶质瘤C6细胞增殖,并促进其凋亡,是治疗胶质瘤较理想的方法． 相似文献
5.
目的：分析神经胶质瘤患者术后放疗同步替莫唑胺（ Temozolomide,TMZ）化疗的临床疗效及其安全性.方法将收治的86例神经胶质瘤术后患者随机分为两组. A组（43例）采用三维适形放疗同步TMZ化疗,B组（43例）采用单纯三维适形放疗,所有治疗均在术后1个月内开始.比较两组患者的临床疗效、术后1,2,3 a的生存率、Karnofsky评分及毒副作用.结果 A组的客观有效率（ Objective response rate,ORR）和疾病控制率（ disease control rate,DCR）分别为76.7%和90.7%,显著高于B组（55.8%和74.4%）（P〈0.05）;治疗后,两组Karnofsky评分均较治疗前有所提高,且A组显著高于B组（P〈0.05）;术后中位生存期及术后1,2,3 a的生存率A组均显著高于B组（P〈0.05）;两组治疗期间的毒副作用比较无统计学意义（P〉0.05）.结论放疗同步TMZ化疗是神经胶质瘤术后一种安全、有效的辅助治疗方法,可提高近远期疗效和术后的生存率,且并不增加药物毒性作用. 相似文献
6.
7.
C. E. Boudreau D. York R. J. Higgins R. A. LeCouteur P. J. Dickinson 《Veterinary and comparative oncology》2017,15(1):133-150
In this study, we determined the expression of key signalling pathway proteins TP53, MDM2, P21, AKT, PTEN, RB1, P16, MTOR and MAPK in canine gliomas using western blotting. Protein expression was defined in three canine astrocytic glioma cell lines treated with CCNU, temozolamide or CPT‐11 and was further evaluated in 22 spontaneous gliomas including high and low grade astrocytomas, high grade oligodendrogliomas and mixed oligoastrocytomas. Response to chemotherapeutic agents and cell survival were similar to that reported in human glioma cell lines. Alterations in expression of key human gliomagenesis pathway proteins were common in canine glioma tumour samples and segregated between oligodendroglial and astrocytic tumour types for some pathways. Both similarities and differences in protein expression were defined for canine gliomas compared to those reported in human tumour counterparts. The findings may inform more defined assessment of specific signalling pathways for targeted therapy of canine gliomas. 相似文献
8.
IMAGING DIAGNOSIS —ANTEMORTEM DETECTION OF OLIGODENDROGLIOMA “CEREBROSPINAL FLUID DROP METASTASES” IN A DOG BY SERIAL MAGNETIC RESONANCE IMAGING 下载免费PDF全文
下载免费PDF全文 Mariana Vigeral R. Timothy Bentley Nicholas J. Rancilio Margaret A. Miller Hock Gan Heng 《Veterinary radiology & ultrasound》2018,59(4):E32-E37
An English Bulldog underwent radiation therapy of an intracranial, left lateral ventricle mass. Following resolution of the primary mass, an intraventricular fourth ventricle lesion developed. Subsequently, multiple lesions developed from the cervical central canal and leptomeninges. Serial magnetic resonance imaging documented the propagation of lesions along the cerebrospinal fluid (CSF) pathways, known as “CSF drop metastasis.” Histopathology confirmed multifocal intraventricular and leptomeningeal oligodendroglioma. Oligodendroglioma should be included in the differential diagnosis for an intraventricular tumor exhibiting apparent CSF drop metastasis. 相似文献
9.
Fernandez FR Grindem CB Brown TT Sharp NJ Saulnier M 《Veterinary clinical pathology / American Society for Veterinary Clinical Pathology》1997,26(4):182-186
A 5-year old female Boxer with a 1-week history of progressive paresis and paraplegia had a T10-13 subarachnoid filling defect on myelography. Exploratory hemilaminectomy revealed an intramedullary spinal cord tumor which was subsequently diagnosed as a poorly differentiated glioma, most likely an anaplastic ependymoma. The cytologic, histologic, and immunocytochemical staining characteristics of this neoplasm are described. Differential diagnoses, including primary and secondary tumors involving the central nervous system are discussed. 相似文献
10.
Objective The purpose of this paper is to classify glial tumors observed in the canine retina and optic nerve, describe the histopathological features and provide prognostic information on these neoplasms. Methods The database of the Comparative Ocular Pathology Laboratory of Wisconsin (COPLOW) was searched to collect canine glioma cases. Clinical and follow-up information was gathered from submission forms and an extensive follow-up survey. Slides were reviewed to describe the histopathological characteristics of the neoplasm and classify them. Immunohistochemistry for Glial Fibrillary Acidic Protein (GFAP) was performed in all cases. Results 18 canine glioma cases were found in the COPLOW database. There was no breed or gender predilection. The mean age was 9.33 ± 3.67 years. Follow-up information was available for 12 dogs, 8 of which were dead at the time of most recent contact, with a survival time ranging from 0 days (globes received after euthanasia) up to 20 months post-enucleation. In 6 of the 8 dogs that had died during this stud), tumor extended to the margin where the optic nerve had been sectioned. Light microscopic examination of the optic nerve of the affected eyes of four dogs that were still alive during this study revealed no tumor at this surgical margin. One neoplasm was classified as low-grade astrocytoma, 5 tumors as medium-grade astrocytoma, 11 tumors as high grade-astrocytoma and 1 tumor as oligodendroglioma. GFAP was positive in all but two tumors. Conclusion Retinal and optic nerve gliomas may be considered as differential diagnoses of intraocular and orbital masses. The metastatic potential appears to be low, but ascending invasion into the ventral aspect of the brain is possible. 相似文献